Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 1 , Pages 87-109 , March 2007

Surgery on neuroendocrine tumours

  • Göran Åkerström, MD (Professor)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +46 18 6114624; Fax: +46 18 504414.

References 

  1. Åkerström G, Hellman P, Hessman O. Gastrointestinal carcinoids. In:  Lennard TWJ editors. Endocrine Surgery. Elsevier; 2006;p. 163–198
  2. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumours. Cancer. 2003;97:934–959
  3. Modlin IM, Kidd M, Latich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128:1717–1751
  4. Delle Fave G, Capurso G, Milione M, Panzuto F. Endocrine tumours of the stomach. Best Practice & Research. Clinical Gastroenterology. 2005;19:659–673
  5. Ichikawa J, Tanabe S, Koizumi W, et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy. 2003;35:203–206
  6. Ahlman H, Kölby L, Lundell L, et al. Clinical management of gastric carcinoid tumors. Digestion. 1994;55(supplement 3):77–85
  7. Bordi C, Corleto VD, Azzoni C, et al. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger–Ellison syndromes. The Journal of Clinical Endocrinology and Metabolism. 2001;86:2236–2242
  8. Bordi C, Falchetti A, Azzoni C, et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. The American Journal of Surgical Pathology. 1997;21:1075–1082
  9. Richards ML, Gauger P, Thompson NW, Giordano TJ. Regression of type II gastric carcinoid in multiple endocrine neoplasia type 1 patients with Zollinger–Ellison syndrome after surgical excision of all gastrinomas. World Journal of Surgery. 2004;28:652–658
  10. Norton JA, Melcher ML, Gibril F, Jensen RT. Gastric carcinoids tumors in multiple endocrine neoplasia-1 patients with Zollinger–Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment. Surgery. 2004;136:1267–1274
  11. Shinohara T, Ohyama S, Nagano H, et al. Minute gastric carcinoid tumor with regional lymph node metastasis. Gastric Cancer. 2003;6:262–266
  12. Wilander E, El-Salhy M, Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology. 1984;8:183–193
  13. Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. World Journal of Surgery. 1996;20:168–172
  14. Rindi G, Azzoni C, La Rosa S, et al. ECL cell tumor and poorly differentiated endocrine carcinoma of the stomach: prognostic evaluation by pathological analysis. Gastroenterology. 1999;116:532–542
  15. Öhrvall U, Eriksson B, Juhlin C, et al. Method of dissection of mesenteric metastases in mid-gut carcinoid tumors. World Journal of Surgery. 2000;24:1402–1408
  16. Makridis C, Öberg K, Juhlin C, et al. Surgical treatment of mid-gut carcinoids tumors. World Journal of Surgery. 1990;14:377–385
  17. Makridis C, Ekbom A, Bring J, et al. Survival and daily physical activity in patients treated for advanced midgut carcinoid tumors. Surgery. 1997;122:1075–1082
  18. Makridis C, Rastad J, Öberg K, Åkerström G. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World Journal of Surgery. 1996;20:900–907
  19. Hellman P, Lundström T, Öhrvall U, et al. Effect of surgery on the outcome of midgut carcinoids disease with lymph node and liver metastases. World Journal of Surgery. 2002;26:991–997
  20. Goede AC, Caplin ME, Winslet MC. Carcinoid tumor of the appendix. The British Journal of Surgery. 2003;90:1317–1322
  21. Stinner B, Rothmund M. Neuroendocrine tumours (carcinoids) of the appendix. Best Practice & Research. Clinical Gastroenterology. 2005;19:729–738
  22. Ballantyne GH, Savoca PE, Flannery JT, et al. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer. 1992;69:2400–2405
  23. Vogelsang H, Siewert JR. Endocrine tumours of the hindgut. Best Practice & Research. Clinical Gastroenterology. 2005;19:739–752
  24. Koura AN, Giacco GG, Curley SA, et al. Carcinoid tumors of the rectum: effect of size, histopathology and surgical treatment on metastasis free survival. Cancer. 1997;79:1294–1298
  25. Suzuki H, Ikeda K. Endoscopic mucosal resection and full thickness resection with complete defect closure for early gastrointestinal malignancies. Endoscopy. 2001;33:437–439
  26. Nakagoe T, Ishikawa H, Sawai T, et al. Gasless video endoscopic transanal excision of rectal tumors incompletely removed by colonoscopic snare polypectomy. Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A. 2003;13:99–103
  27. Åkerström G, Hellman P, Hessman O, Osmak L. Surgical treatment of endocrine pancreatic tumours. Neuroendocrinology. 2004;80(supplement 1):62–66
  28. Scarlett JA, Mako ME, Rubenstein AH, et al. Factitious hypoglycemia: diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies. The New England Journal of Medicine. 1977;297:1029–1032
  29. Thompson NW, Dzako PF, Fritts LL, et al. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery. 1994;116:1131–1138
  30. Anderson MA, Carpenter S, Thompson NW, et al. Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. The American Journal of Gastroenterology. 2000;95:2271–2277
  31. Doppman JL, Chang R, Fraker DL, et al. Localization of insulinomas to regions of the pancreas by intra-arterial stimulation with calcium. Annals of Internal Medicine. 1995;123:269
  32. Grant CS. Insulinoma. Best Practice & Research Clinical Gastroenterology. 2005;19:783–798
  33. Service GJ, Thompson GB, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. The New England Journal of Medicine. 2005;353:249–254
  34. Imamura M, Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger–Ellison syndrome. World Journal of Surgery. 1993;17:433–438
  35. Norton JA, Fraker DL, Alexander HR. Surgery to cure the Zollinger–Ellison syndrome. The New England Journal of Medicine. 1999;341:635–644
  36. Yu F, Venzon DJ, Serrano J, et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger–Ellison Syndrome. Journal of Clinical Oncology. 1999;17:615–630
  37. Doherty GM. Rare endocrine tumours of the GI tract. Best Practice & Research. Clinical Gastroenterology. 2005;19:807–818
  38. Hellman P, Andersson M, Rastad J, et al. Surgical strategy for large or malignant endocrine pancreatic tumours. World Journal of Surgery. 2000;24:1353–1360
  39. Kouvaraki MA, Solorzano CC, Shapiro SE, et al. Surgical treatment of non-functioning pancreatic islet cell tumors. Journal of Surgical Oncology. 2005;89:170–185
  40. Öberg K, Eriksson B. Endocrine tumours of the pancreas. Best Practice & Research. Clinical Gastroenterology. 2005;19:753–782
  41. Bartsch DK, Schilling T, Ramaswamy A, et al. Management of nonfunctioning isle cell carcinomas. World Journal of Surgery. 2000;24:1418–1424
  42. Åkerström G, Hessman O, Hellman P, Skogseid B. Pancreatic tumours as part of the MEN-1 syndrome. Best Practice & Research. Clinical Gastroenterology. 2005;19:819–830
  43. Dean PG, van Heerden JA, Farley DR, et al. Are patients with multiple endocrine neoplasia type 1 prone to premature death?. World Journal of Surgery. 2000;1:1437–1441
  44. Doherty GM, Olson JA, Frisella MM, et al. Lethality of multiple endocrine neoplasia type 1. World Journal of Surgery. 1998;22:581–587
  45. Åkerström G, Hessman O, Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumours of the pancreas in MEN 1. Langenbeck's Archives of Surgery. 2002;386:558–569
  46. Skogseid B, Rastad J, Åkerström G. Pancreatic endocrine tumors in multiple endocrine neooplasia type 1. In:  Doherty G,  Skogseid B editor. Surgical Endocrinology. Philadelphia, Lippincott: Williams & Wilkins; 2001;p. 511–525
  47. Gauger PG, Scheiman JM, Wamsteker E-M, et al. Role of endoscopic ultrasound in screening and treatment of pancreatic endocrine tumours in asymptomatic patients with multiple endocrine neoplasia type 1. The British Journal of Surgery. 2003;90:748–754
  48. Hellman P, Hennings J, Åkerström G, Skogseid B. Endoscopic ultrasonography for evaluation of pancreatic tumours in multiple endocrine neoplasia type 1. The British Journal of Surgery. 2005;92:1508–1512
  49. Doherty GM. Multiple endocrine neoplasia type 1: duodenopancreatic tumors. Surgical Oncology. 2003;12:135–143
  50. McEntee GP, Nagorney DM, Kvols CK, et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990;108:1091–1096
  51. Wängberg B, Westberg G, Tylén U, et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World Journal of Surgery. 1996;20:892–899
  52. Nave H, Mössinger E, Feist H, et al. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery. 2001;129:170–175
  53. Hellman P, Ladjevardi S, Skogseid B, et al. Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World Journal of Surgery. 2002;26:1052–1056
  54. Elias D, Lasser P, Ducreux M, et al. Liver resection (and associated extrahepatic resections) for metastatic well-diferentiated endocrine tumors: a 15-year single center prospective study. Surgery. 2003;133:375–382
  55. Norton JA, Warren RS, Kelly MF, et al. Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery. 2003;134:1057–1065

PII: S1521-690X(06)00113-8

doi: 10.1016/j.beem.2006.12.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 21, Issue 1 , Pages 87-109 , March 2007

Article Tools

* Image Usage & Resolution